Market Overview

UPDATE: ICU Medical Posts 31% Decline In Q4 Profit, Issues Downbeat FY13 Forecast

Related ICUI
Bear of the Day: ICU Medical (ICUI) - Bear of the Day
ICU Medical Reports Two Clinical Studies Demonstrated Chemoclave Reduced Hazardous Drug Exposure

ICU Medical (NASDAQ: ICUI) reported a 31% drop in its fourth-quarter earnings.

For the new year, ICU Medical projects earnings of $2.70 to $2.85 per share, and revenue of $330 million to $340 million. However, analysts expected earnings of $2.89 per share on revenue of $339 million.

ICU Medical's quarterly profit declined to $12.3 million, or $0.82 per share, from $17.8 million, or $1.26 per share, in the year-ago period.

Its revenue climbed 8.1% to $82.7 million. However, analysts were expecting earnings of $0.78 per share on revenue of $83 million.

Its gross margin rose to 50.6% from 47.1%.

ICU Medical shares fell 1.50% to close at $60.24 yesterday.

Posted-In: profitEarnings News Guidance

 

Most Popular

Related Articles (ICUI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free